All Categories chevron icon Imaging Systems chevron icon Oncology chevron icon Oncology: Medical
2010 Category Leader Oncology

2010 KLAS Category Leader Oncology

2024 BEST IN KLAS

Who is theKLAS Category Leader?

Solutions Not Ranked

Limited Data Products

Score

US Oncology iKnowMed (Ambulatory Only)*

81.8

Component [C], Not Primary [NP], Regional [R] or Limited Market Share [MS]

Beacon (Acute Chemotherapy CPOE Only) [C]*

83.4

*Does not meet minimum KLAS Konfidence level.

Trend does not include the Best KLAS score

See the latest BEST IN KLAS 2018

2024 Best in KLAS Awards - Global Software
2024 GLOBAL
2024 Best in KLAS Awards - Software and Services
2024 BEST IN KLAS

How do Oncology solutions compare?


Past Oncology Awards

2024
Oncology: Medical 2024 Oncology: Medical
2023
Oncology: Medical 2023 Oncology: Medical
2022
Oncology: Medical 2022 Oncology: Medical
2021
Oncology - Medical 2021 Oncology - Medical
2020
Oncology - Medical 2020 Oncology - Medical
2019
Oncology 2019 Oncology
2018
Oncology 2018 Oncology
2017
Oncology 2017 Oncology
2015/2016
Oncology 2016 Oncology
2014
Oncology 2014 Oncology
2013
Oncology 2013 Oncology
2012
Oncology 2012 Oncology
2011
Oncology 2011 Oncology
2010
Oncology 2010 Oncology
2009
Oncology 2009 Oncology
2008
Oncology 2008 Oncology
Related ReportsView All Reports
Performance
KLAS article icon
Epic Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Epic “complete look” provides a high-level analysis of the key products that make up Epic’s enterprise suite. (Other reports in the series do the same for Altera Digital Health [Allscripts] , Evident , MEDITECH , and Oracle Health [Cerner] .)
Performance
KLAS article icon
Altera Digital Health (Allscripts) Complete Look 2023
18 July 23    |   Paul Warburton and Tyson Blauer
When making a core HIT purchasing decision, healthcare organizations must take into account how prospective partners deliver across a variety of key technology areas. This Altera Digital Health (Allscripts) Sunrise “complete look” provides a high-level analysis of the key products that make up Altera Digital Health’s enterprise suite. (Other reports in the series do the same for Epic , Evident , MEDITECH , and Oracle Health [Cerner] .) This report focuses on the core Sunrise suite and its supporting technology; data on Altera Digital Health’s standalone ambulatory platforms (TouchWorks and Professional) is excluded.
Performance
KLAS article icon
Oncology 2023
06 June 23    |   Monique Rasband and Spencer Corbett
The market for both medical and radiation oncology EMRs is shifting. For medical oncology, many previously independent oncology practices and cancer centers have been consolidated into larger health systems, leading to the adoption of medical oncology modules from acute care EMR vendors—a trend that is set to continue. Additionally, customer satisfaction in the radiation oncology market has shifted in recent years as the two primary vendors have competed for each other’s customers. Leveraging the perspectives of 158 organizations, this report explores the performance of medical and radiation oncology EMR vendors to see which are meeting customer needs and which are falling behind.

Konfidence

Konfidence level
Konfidence Level Description
Products must have at least 30 live organizations participating for software and at least 15 live organizations for professional services. Exception to this is Transcription Services (30).
Products must have at least 20 live organizations participating for software and at least 10 live organizations for professional services. Exception to this is Transcription Services (20).
Products must have at least 15 live organizations participating for software and at least 6 live organizations for professional services. Exception to this is Transcription Services
-
The Konfidence level on this product rating is low. These results are for early trend detection. As more performance data is received, the result is likely to have a wide variance.
We use cookies! We use essential and basic aggregated, depersonalized Google Analytics cookies to provide the type of content which our visitors are most interested in.  Cookie Policy    
​